<DOC>
	<DOCNO>NCT02000102</DOCNO>
	<brief_summary>Patients diabetic macular edema switch aflibercept treat bevacizumab ranibizumab retrospectively review assess visual acuity anatomic outcome .</brief_summary>
	<brief_title>Outcomes Diabetic Macula Edema Patients Switched Aflibercept From Bevacizumab and/or Ranibizumab</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Those patient diabetic macular edema switch aflibercept bevacizumab and/or ranibizumab None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>